EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Combined Central and Peripheral Demyelination (CCPD) Associated with MOG Antibodies: Report of Four New Cases and Narrative Review of the Literature

Marianna Papadopoulou iD, Dimitrios Tzanetakos iD, Christos Moschovos, Anastasia Korona, George Vartzelis, Konstantinos Voudris, Stella Fanouraki, Evangelia-Makrina Dimitriadou, Georgios Papadimas iD, John S Tzartos, Sotirios Giannopoulos iD, Georgios Tsivgoulis iD

Journal of Clinical Medicine · 20.06.2024 · 13 (12) · 3604

DOI: 10.3390/jcm13123604 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.06.2024. Verfasst von Marianna Papadopoulou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Gree…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Myelin oligodendrocyte glycoprotein (MOG) is exclusively expressed in the central nervous system (CNS) and is found on the outer surface of oligodendrocytes. Antibodies to MOG are associated with CNS demyelination, whereas peripheral nervous system (PNS) demyelination is seldom reported to be related to MOG-IgG.

Methods

The database of patients seen in our neurological academic center was searched for MOG-IgG seropositivity and concomitant demyelinating polyneuropathy. For the purpose of the review, in March 2024, we searched for case reports and case series in the following databases: PubMed, Scopus, Cochrane, and ScienceDirect. Inclusion criteria were MOG-IgG seropositivity and demyelinating polyneuropathy. Exclusion criteria were type of publication other than case reports and case series, unconfirmed diagnosis of demyelinating polyneuropathy, and other diseases causing demyelination in either the CNS or PNS. Critical appraisal of the selected case reports and case series was realized by JBI.

Results

Four new cases were identified with MOG-IgG and confirmed demyelinating polyneuropathy. This review identified 22 cases that have been published since 2018. Clinical, imaging, neurophysiological, and immunological characteristics, as well as treatment options and outcomes are presented and compared to those of other cases with combined central and peripheral demyelination (CCPD).

Conclusions

The pathogenetic mechanism is unclear; thus, different hypotheses are discussed. New case reporting and large cohort studies will help further the exploration of the underlying mechanism and guide more effective therapeutic interventions.

Schlagwörter

Stichwörter der Autor:innen

MOGcombined central and peripheral demyelinationdemyelinating polyneuropathy

Autor:innen und Institutionen

  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Department of Physiotherapy, University of West Attica, Ag. Spyridonos Str., 12243 Athens, Greece.
  • Department of Neurology, Children's Hospital of Athens "P. & A. Kyriakou", 11527 Athens, Greece.
  • Second Department of Pediatrics, Children's Hospital 'P. & A. Kyriakou', School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • First Department of Neurology, National and Kapodistrian University of Athens, Eginition University Hospital School of Medicine, 11528 Athens, Greece.
  • Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Marianna Papadopoulou, Dimitrios Tzanetakos, Georgios Papadimas, Sotirios Giannopoulos, Georgios Tsivgoulis

Zitieren

APA

Papadopoulou, M., Tzanetakos, D., Moschovos, C., Korona, A., Vartzelis, G., Voudris, K., Fanouraki, S., Dimitriadou, E. M., Papadimas, G., Tzartos, J. S., Giannopoulos, S., & Tsivgoulis, G. (2024). Combined Central and Peripheral Demyelination (CCPD) Associated with MOG Antibodies: Report of Four New Cases and Narrative Review of the Literature. Journal of Clinical Medicine, 13(12), 3604. https://doi.org/10.3390/jcm13123604

Vancouver

Papadopoulou M, Tzanetakos D, Moschovos C, Korona A, Vartzelis G, Voudris K, et al. Combined Central and Peripheral Demyelination (CCPD) Associated with MOG Antibodies: Report of Four New Cases and Narrative Review of the Literature. Journal of Clinical Medicine. 2024;13(12):3604. doi:10.3390/jcm13123604

BibTeX
@article{Papadopoulou2024,
  author = {Papadopoulou, Marianna and Tzanetakos, Dimitrios and Moschovos, Christos and Korona, Anastasia and Vartzelis, George and Voudris, Konstantinos and Fanouraki, Stella and Dimitriadou, Evangelia-Makrina and Papadimas, Georgios and Tzartos, John S and Giannopoulos, Sotirios and Tsivgoulis, Georgios},
  title = {Combined Central and Peripheral Demyelination (CCPD) Associated with MOG Antibodies: Report of Four New Cases and Narrative Review of the Literature},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {3604},
  doi = {10.3390/jcm13123604}
}
Kostenlos starten →